Congress Urged To Address Expanded OMB Role In Regulations, Guidances
This article was originally published in The Gray Sheet
Executive Summary
The nonpartisan government watchdog group OMB Watch is urging Congress to take action against an executive order that increases the administration's influence over regulations and guidance documents issued by FDA and other agencies